CIK 0001448431
- Non-accelerated filer
- Smaller reporting company
OptimizeRx Corp
Sign in to watch- Ticker
- OPRX
- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261265381
- Phone
- +1 248-651-6558
- Business address
- 260 CHARLES STREET, SUITE 302, WALTHAM, MA, 02453
- 4 Grant or award CEO acquired 15,000 shares (grant or award)
- 4 Grant or award Chief Product Officer acquired 4,000 shares (grant or award)
- 4 Grant or award General Counsel and CCO acquired 4,267 shares (grant or award)
- 4 Grant or award CFO/COO acquired 7,083 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 7,750 shares (grant or award)
- 4/A Exercise or conversion CFO/COO acquired 8,221 shares (option exercise)
- 4/A Shares withheld for taxes CFO/COO gave up 3,539 shares (to pay taxes)
- 4 Grant or award CEO acquired 60,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 668 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and CCO gave up 268 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes General Counsel and CCO gave up 1,386 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO gave up 2,884 shares (to pay taxes)
- 4 Planned sale General Counsel and CCO sold 4,000 shares at $15.19 ($60,751)
- 4 Shares withheld for taxes General Counsel and CCO gave up 524 shares (to pay taxes)
Page 6 of 23 · 444 filings